Citation Impact
Citing Papers
Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis
2008 Standout
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2008 Standout
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
2010 Standout
Oral cavity and oropharyngeal squamous cell carcinoma—an update
2015 Standout
FUNC: a package for detecting significant associations between gene sets and ontological annotations
2007 StandoutNobel
ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform
2004 Standout
Long-term Cognitive Impairment and Functional Disability Among Survivors of Severe Sepsis
2010 Standout
Toxicity and outcome results of RTOG 9311: A phase I–II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non–small-cell lung carcinoma
2005
Nasopharyngeal carcinoma
2005 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
Randomized Phase III Trial of Neoadjuvant Chemotherapy in Head and Neck Cancer: 10-Year Follow-Up
2004
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Prevention of irradiation-induced esophagitis by plasmid/liposome delivery of the human manganese superoxide dismutase transgene
1999
Induction of resistance to the multitargeted antifolate Pemetrexed (ALIMTA) in WiDr human colon cancer cells is associated with thymidylate synthase overexpression
2003
Pulmonary Toxicity Associated With the Treatment of Non-Small Cell Lung Cancer and the Effects of Cytoprotective Strategies
2005
3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease
2007
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
2009 Standout
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
2009 Standout
Delirium in elderly people
2013 Standout
Treatment of Non-small Cell Lung Cancer-Stage IIIA
2007
Lung Cancer
2008 Standout
Multidisciplinary Approach to Cancer Treatment: Focus on Head and Neck Cancer
2008
Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment
2016 Standout
Pathway level analysis of gene expression using singular value decomposition
2005
Mild Cognitive Impairment
2011 Standout
Head and neck cancer
2008 Standout
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Lung Cancer: Epidemiology, Etiology, and Prevention
2011 Standout
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2014 Standout
GSVA: gene set variation analysis for microarray and RNA-Seq data
2013 Standout
Accelerated Hyperfractionation in Patients with Non-Small Cell Bronchogenic Cancers as a Cost-Effective and User- and Patient-Friendly Schedule
2000
Non-small cell lung cancer clinical trials with trastuzumab: their foundation and preliminary results
2002
Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy—results of a multicentric randomized German trial in advanced head-and-neck cancer
2001
The role of new agents in the treatment of non-small cell lung cancer
2002
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
2009 Standout
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Hierarchical feature representation and multimodal fusion with deep learning for AD/MCI diagnosis
2014 Standout
Randomized Trial of Induction Chemotherapy With Cisplatin and 5-Fluorouracil With or Without Docetaxel for Larynx Preservation
2009
Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists
2008 Standout
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
2009 Standout
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Novel agents and incremental advances in the treatment of head and neck cancer
2004
The pathobiology of mucositis
2004 Standout
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
2013 Standout
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
2007 Standout
Genetic Network Modeling
2002
Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study
2004
End points for new agents in induction chemotherapy for locally advanced head and neck cancers
2002
Adjusting for patient selection suggests the addition of docetaxel to 5-fluorouracil–cisplatin induction therapy may offer survival benefit in squamous cell cancer of the head and neck
2004
Measuring cognitive reserve based on the decomposition of episodic memory variance
2010
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2020 Standout
Genomics, Prior Probability, and Statistical Tests of Multiple Hypotheses
2004
Lung Cancer in Women
2005
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Large-scale brain networks and psychopathology: a unifying triple network model
2011 Standout
Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer
2007 Standout
A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma
2002
Radiotherapy with concomitant weekly docetaxel for Stages III/IV oropharynx carcinoma. Results of the 98-02 GORTEC Phase II trial
2003
The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis
2010 Standout
Modeling and Simulation of Genetic Regulatory Systems: A Literature Review
2002 Standout
Paradigm Shift in the Treatment of Head and Neck Cancer: The Role of Neoadjuvant Chemotherapy
2005
MEGO: Gene Functional Module Expression Based on Gene Ontology
2005
Induction Chemotherapy for Head and Neck Cancer: Will History Repeat Itself?
2005
Folate depletion increases sensitivity of solid tumor cell lines to 5-fluorouracil and antifolates
2000
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Hippocampal and entorhinal atrophy in mild cognitive impairment
2007
Delirium accelerates cognitive decline in Alzheimer disease
2009
Role of Taxoids in Head and Neck Cancer
2000
VBM anticipates the rate of progression of Alzheimer disease
2008
Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx Cancer
2012 Standout
Mutations in the Epidermal Growth Factor Receptor and in KRAS Are Predictive and Prognostic Indicators in Patients With Non–Small-Cell Lung Cancer Treated With Chemotherapy Alone and in Combination With Erlotinib
2005
Diagnosis and Management of Cerebral Venous Thrombosis
2011 Standout
Antifolate Activity of Epigallocatechin Gallate against Stenotrophomonas maltophilia
2005 Standout
ARACNE: An Algorithm for the Reconstruction of Gene Regulatory Networks in a Mammalian Cellular Context
2006 Standout
Chemotherapy Options for Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck
2006
Religious Orders Study and Rush Memory and Aging Project
2018 Standout
Oral complications of cancer therapy.
2002
Impact of Natural Products on Developing New Anti-Cancer Agents
2009 Standout
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Cognitive impairment risk
2009
Durable Long-Term Remission With Chemotherapy Alone for Stage II to IV Laryngeal Cancer
2009
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Atrophy rates accelerate in amnestic mild cognitive impairment
2007
White matter hyperintensities, incident mild cognitive impairment, and cognitive decline in old age
2016
Works of S. Adak being referenced
Phase I/II Trial of Outpatient Docetaxel, Cisplatin, 5-Fluorouracil, Leucovorin (opTPFL) as Induction for Squamous Cell Carcinoma of the Head and Neck (SCCHN)
2002
A phase II trial of palliative docetaxel plus 5-fluorouracil for squamous-cell cancer of the head and neck
2000
Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trial.
1998
The influence of gender on survival and tumor recurrence following adjuvant therapy of completely resected stages II and IIIa non-small cell lung cancer
2002
Phase II Eastern Cooperative Oncology Group (ECOG) pilot study of paclitaxel (P), carboplatin (C), and trastuzumab (T) in HER-2/neu (+)advanced non-small cell lung cancer (nsclc): early analysis of e2598
2001
Predicting the rate of cognitive decline in aging and early Alzheimer disease
2004
Phase II Trial of Docetaxel, Cisplatin, Fluorouracil, and Leucovorin as Induction for Squamous Cell Carcinoma of the Head and Neck
1999
GENOME-WIDE PATHWAY ANALYSIS AND VISUALIZATION USING GENE EXPRESSION DATA
2001
2 Randomized prospective comparison of adjuvant mediastinal radiation (RT) with or without concurrent chemotherapy with cisplatin and etoposide (PE) for patients with completely resected 51-3N1-2M0 non-small cell lung cancer (NSCLC): US
1999
Phase II trial of hyperfractionated accelerated radiation therapy for nonresectable non-small-cell lung cancer: results of Eastern Cooperative Oncology Group 4593.
1998